DURECT Corporation (DRRX)
Symbol Info
Listed Symbol DRRX
Name DURECT Corporation
Share Info
Annual Info
Latest Fiscal Dividend Per Share $-
Latest Fiscal Date 2018-12-31
Latest Fiscal Revenue $18,564,000
Latest Fiscal EPS $-0.16
Price Info
21 Day Moving Average $1.9171
21 Day EMA $1.854990
50 Day Moving Average $1.7382
50 Day EMA $1.688420
200 Day EMA $1.202230
200 Day Moving Average 0.956620
52 Week High $2.46
52 Week Low $0.46
52 Week Change $95.098000
Alpha 0.037301
Beta 1.7659
Standard Deviation 0.268321
R2 0.051081
Periods 60
Share Information
10 Day Average Volume 512,633
20 Day Average Volume 915,133
30 Day Average Volume 953,843
50 Day Average Volume 879,982
Outstanding Shares 191,942,234
Float Shares 186,566,519
Percent Float 97.20%
Short Interest -
Short Percent Float -
Short Interest Ratio -
Short Date
Holders
Institutions 162
Institute Holdings Date 2019-09-30
Institute Bought Previous 3 Months 9,581,933
Institute Holdings Percent 49.900000
Institute Sold Previous 3 Months 22,571,563
Insider Holdings Date 2019-08-31
Insider Bought Previous 3 Months 25
Insider Holdings Percent 2.80%
Insider Sold Previous 3 Months -
Insiders Shares Owned 5,375,715
Price Change
7 Day Price Change $0.2900000
7 Day Percent Change 17.06%
21 Day Price Change $0.0100000
21 Day Percent Change 0.51%
30 Day Price Change $0.0500000
30 Day Percent Change 2.58%
Month To Date Price Change $0.1500
Month To Date Percent 8.15%
90 Day Price Change $1.316100
90 Day Percent Change 195.30%
Quarter To Date $0.150000
Quarter To Date Percent 8.15%
180 Day Price Change $1.417500
180 Day Percent Change 247.60%
200 Day Price Change $1.379000
200 Day Percent Change 225.70%
Year To Date $1.506900
Year To Date Percent 311.92%
Profile
Description Durect Corp is a biopharmaceutical company. It is engaged in the research, development and manufacturing of pharmaceutical products. The company develops pharmaceutical products based on two categories which include new chemical entities and drug delivery programs. The company's pipeline products consist of DUR-928, RBP-7000, Remoxy, POSIMIR, and others.
Details
Issue Type CS
Market Cap $381,965,046
Sec Type EQS
Auditor Ernst & Young LLP
Total Shares Outstanding 191,942,234
CEO James E. Brown
Employees 85
Last Audit UQ
Classification
CIK 0001082038
Industry Drug Manufacturers
Sector Healthcare
NAICS Pharmaceutical Preparation Manufacturing(325412)
Info
Address 10260 Bubb Road
Cupertino, CA 95014-4166
Website http://www.durect.com
Facisimile +1 408 777-3577
Telephone +1 408 777-1417
Email mike.arenberg@durect.com
Key Ratios
Profitability
EBIT Margin -110.2
EBITDA Margin -109.3
Pre-Tax Profit Margin -124.5
Profit Margin Cont -
Gross Margin 79.70
Profit Margin TOT -
Income Statements
Revenue $11,743,000
Revenue Per Share $0.0612
Revenue 3 Years $-0.14
Revenue 5 Years $0.54
Valuation Measures
PE Ratio -
Enterprise Value $343,201,710
Price To Sales 32.527042
Price To Free Cash -19.3
PE High Last 5 Years -
Price To Book 15.1
Price To Cash Flow 200.6
PE Low Last 5 Years -
Price To Tangible Book 21.0
Financial Strength
Total Debt To Equity 1.2
Int Coverage -8.5
Current Ratio 4.3
Leverage Ratio 3.4
Quick Ratio 3.8
Long Term Debt To Capital 0.52
Assets
Receivables Turnover 2.5
Invoice Turnover 1.10
Assets Turnover 0.10
Management Effectiveness
Return Assets -41.52
Return On Equity -95.27
Return On Capital -45.78
Dividends
Dividend 3 Years $-
Dividend 5 Years $-
Ex Dividend Date
Dividend Rate $-
Dividend Yield -
Payment Type


Your Recent History
NASDAQ
DRRX
Durect
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.